TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 10.6B
Gross Profit 4.0B 38.07%
Operating Income 2.0B 19.25%
Net Income 1.8B 16.85%
EPS (Diluted) ₹3.57

Balance Sheet Metrics

Total Assets 39.6B
Total Liabilities 10.6B
Shareholders Equity 29.1B
Debt to Equity 0.36

Cash Flow Metrics

Revenue & Profitability Trend

Sumitomo Chemical Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i31.2B28.2B34.7B30.4B26.2B
Cost of Goods Sold i18.8B18.0B22.9B19.2B16.7B
Gross Profit i12.4B10.2B11.9B11.1B9.5B
Gross Margin % i39.6%36.2%34.2%36.6%36.4%
Operating Expenses
Research & Development i15.8M13.4M11.2M12.0M7.8M
Selling, General & Administrative i1.5B1.2B1.4B1.5B1.3B
Other Operating Expenses i1.6B1.5B1.6B1.5B1.3B
Total Operating Expenses i3.2B2.8B3.1B3.0B2.6B
Operating Income i5.7B4.3B6.2B5.6B4.4B
Operating Margin % i18.2%15.2%17.7%18.5%17.0%
Non-Operating Items
Interest Income i822.8M590.0M249.4M103.5M99.5M
Interest Expense i47.0M35.9M38.5M47.2M41.0M
Other Non-Operating Income-----
Pre-tax Income i6.8B5.0B6.5B5.8B4.5B
Income Tax i1.7B1.3B1.5B1.5B1.1B
Effective Tax Rate % i25.5%26.5%23.2%26.4%23.8%
Net Income i5.1B3.7B5.0B4.2B3.5B
Net Margin % i16.2%13.1%14.5%14.0%13.2%
Key Metrics
EBITDA i7.2B5.5B6.9B6.1B5.0B
EPS (Basic) i₹10.13₹7.40₹10.06₹8.49₹6.92
EPS (Diluted) i₹10.13₹7.40₹10.06₹8.49₹6.92
Basic Shares Outstanding i499145736499145736499145736499145736499145736
Diluted Shares Outstanding i499145736499145736499145736499145736499145736

Income Statement Trend

Sumitomo Chemical Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i382.3M466.4M468.9M572.5M1.9B
Short-term Investments i12.2B8.4B2.6B5.2B3.4B
Accounts Receivable i7.8B7.2B9.5B8.4B8.5B
Inventory i7.0B6.1B8.9B9.4B7.5B
Other Current Assets1.2B998.0M1.3B10.0K280.0K
Total Current Assets i30.2B26.7B27.9B25.2B23.0B
Non-Current Assets
Property, Plant & Equipment i258.9M250.3M171.4M134.1M126.9M
Goodwill i1.5B1.5B215.5M184.6M105.7M
Intangible Assets i257.8M247.7M215.5M184.6M105.7M
Long-term Investments-----
Other Non-Current Assets56.8M28.4M250.0K-110.0K175.7M
Total Non-Current Assets i9.4B6.4B5.8B4.9B3.7B
Total Assets i39.6B33.1B33.7B30.1B26.7B
Liabilities
Current Liabilities
Accounts Payable i4.9B4.3B4.9B5.2B5.9B
Short-term Debt i191.1M117.4M162.3M128.6M173.0M
Current Portion of Long-term Debt-----
Other Current Liabilities647.4M531.8M512.2M797.6M1.1B
Total Current Liabilities i9.7B8.0B9.3B10.2B10.8B
Non-Current Liabilities
Long-term Debt i327.8M185.1M177.4M247.2M153.3M
Deferred Tax Liabilities i265.7M236.3M136.3M139.1M50.4M
Other Non-Current Liabilities-----
Total Non-Current Liabilities i941.7M680.2M539.3M609.7M495.8M
Total Liabilities i10.6B8.7B9.9B10.8B11.3B
Equity
Common Stock i5.0B5.0B5.0B5.0B5.0B
Retained Earnings i3.6B2.2B1.6B1.6B1.5B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i29.1B24.4B23.8B19.3B15.4B
Key Metrics
Total Debt i518.9M302.5M339.7M375.8M326.4M
Working Capital i20.6B18.7B18.5B15.0B12.2B

Balance Sheet Composition

Sumitomo Chemical Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i6.8B5.0B6.5B5.8B4.5B
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-837.0M4.5B-1.1B-1.5B-845.8M
Operating Cash Flow i5.2B9.0B5.2B3.9B3.6B
Investing Activities
Capital Expenditures i-285.9M-619.0M-1.2B-1.1B-428.2M
Acquisitions i0-578.5M0--
Investment Purchases i-18.9B-19.4B-15.5B-7.8B-6.4B
Investment Sales i14.6B15.9B13.3B6.0B4.0B
Investing Cash Flow i-4.6B-4.7B-3.4B-3.0B-2.9B
Financing Activities
Share Repurchases i-----
Dividends Paid i-440.3M-3.1B-499.4M-400.2M-275.2M
Debt Issuance i-----
Debt Repayment i-5.1M-53.5M0-0
Financing Cash Flow i-450.4M-3.2B-499.4M-400.2M-275.2M
Free Cash Flow i4.2B6.9B2.7B1.1B3.8B
Net Change in Cash i173.2M1.1B1.3B551.3M442.0M

Cash Flow Trend

Sumitomo Chemical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 52.19
Forward P/E 40.03
Price to Book 10.00
Price to Sales 8.62
PEG Ratio 1.41

Profitability Ratios

Profit Margin 16.55%
Operating Margin 19.25%
Return on Equity 17.40%
Return on Assets 12.75%

Financial Health

Current Ratio 3.13
Debt to Equity 1.79
Beta 0.05

Per Share Data

EPS (TTM) ₹11.14
Book Value per Share ₹58.12
Revenue per Share ₹67.42

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sumichem290.2B52.1910.0017.40%16.55%1.79
Coromandel 712.9B31.546.4218.41%8.56%6.95
UPL 622.8B3.001.632.01%0.09%105.06
PI Industries 586.6B35.375.7817.58%20.81%1.81
UPL 565.8B50.761.992.01%2.55%66.35
Bayer CropScience 247.6B41.728.6919.93%10.29%3.69

Financial data is updated regularly. All figures are in the company's reporting currency.